GB Patent

GB202404661D0 — Antisense oligoncleotides for the treatment of liver disease

Assigned to ProQR Therapeutics II BV · Expires 2024-05-15 · 2y expired

What this patent protects

Patent listed against eplontersen-sodium.

Drugs covered by this patent

eplontersen-sodium (EPLONTERSEN SODIUM)

Patent Metadata

Patent number: GB202404661D0
Jurisdiction: GB
Classification: —
Expires: 2024-05-15
Drug substance claim: No
Drug product claim: No
Assignee: ProQR Therapeutics II BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.